Beximco Limited, Beximco Pharma post stellar growth in Q1
Beximco Group’s concern Shinepukur Ceramics’ profits dropped as costs increased amid a subdued growth in sales
Beximco Limited and Beximco Pharmaceuticals have posted stellar growth in sales and profits for the July-September quarter, compared to that in the same period of 2020.
However, the Beximco Group's concern Shinepukur Ceramics' profits dropped as costs increased amid a subdued growth in sales.
Beximco Limited
Keep updated, follow The Business Standard's Google news channel
The conglomerate's sales and profits have been rising sharply since the end of the first wave of Covid-19 as all its businesses are growing in addition to its lucrative income from exports of high quality personal protective equipment (PPE).
Its quarterly revenue rose to Tk1,758 crore from Tk653 crore a year ago, while the net profit after all taxes grew to over Tk450 crore from less than Tk87 crore in the July-September 2020 quarter.
Its quarterly earnings per share (EPS) rose to Tk4.11 from Tk0.14 and the net asset value (NAV) per share stood at Tk83.42.
Beximco Pharmaceuticals
Beximco Pharmaceuticals, a leading drug maker of the country, registered quarterly sales of Tk847 crore in July-September this year, up from Tk693 crore in the same quarter last year.
Its EPS for the first quarter of this fiscal year grew to Tk3.28 from Tk2.41 a year ago.
The company earned a lot from supplying Covid-19 vaccines last year, while its export and local market too kept growing.
Shinepukur Ceramics' profit drop
Shinepukur Ceramics' quarterly EPS dropped to Tk0.02 this year from Tk0.05 a year ago.
This company's sales in the July-September period slightly grew to Tk36.4 crore from Tk33.3 crore in the corresponding quarter of 2020.
But the increased cost of goods sold squeezed its gross profits and the company managed to save a meagre amount through saving some operating and financial expenses.
